A Biotech Bash - Recs and Wrecks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Biotech Bash - Recs and Wrecks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: r. peter Dale who wrote ()	8/28/1997 9:19:00 PM
From: r. peter Dale	of 171

Tonight's company...Protein Design Labs. Those in the know, give us your best: (just the science; details about the Roche involvement etc. should be omitted) What are PDLI scientific strengths? What is the core direction/objective of the company? Tell us about Zenapax (humanized antibody against the interleukin-2 receptor), its efficaciousness in blocking transplant rejection, other uses for the drug, clinical trial stage, etc. Also, tell us about Dacliximab (humanized anti-TAC): tell us about TAC and why interfering with it is a treatment for relapsing-remitting multiple sclerosis. What other drugs are on the horizon? Who are PDLI competitors and what are their STRENGTHS? PDLI appears to have outperformed most of the biotech sector. I await the answers with bloated breath. Best wishes, Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next